Search Results

Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than Enterococcus faecalis or E. faecium in Patients With Cancer.

• Authors : Axell-House, Dierdre B; Ashley, Patrycja A; Egge, Stephanie L

Subjects: ENTEROCOCCUS; ENTEROCOCCAL infections; ENTEROCOCCUS faecalis

• Source: Open Forum Infectious Diseases; Jun2024, Vol. 11 Issue 6, p1-9, 9p

Record details

Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.

• Authors : Westbrook, Kevin J; Chilambi, Gayatri Shankar; Stellfox, Madison E

Subjects: ENTEROCOCCUS; INFECTIVE endocarditis; ENTEROCOCCUS faecalisUNIVERSITY of Pittsburgh

• Source: Journal of Antimicrobial Chemotherapy (JAC); Apr2024, Vol. 79 Issue 4, p801-809, 9p

Record details

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.

• Authors : Shropshire, William C; Endres, Bradley T; Borjan, Jovan

Subjects: CEFTAZIDIME; ESCHERICHIA coli; AMINO acid residues

• Source: Journal of Antimicrobial Chemotherapy (JAC); Oct2023, Vol. 78 Issue 10, p2442-2450, 9p

Record details

Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA.

• Authors : Sakurai, Aki; Dinh, An Q.; Hanson, Blake M.

• Source: JAC-Antimicrobial Resistance; Jun2023, Vol. 5 Issue 3, p1-9, 9p

Record details

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.

• Authors : Tran, Truc T.; Cabrera, Nicolo L.; Gonzales-Luna, Anne J.

• Source: JAC-Antimicrobial Resistance; Feb2023, Vol. 5 Issue 1, p1-9, 9p

Record details

Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.

• Authors : Streling, Ana Paula; Obaidi, Mohanad M Al; Lainhart, William D

Subjects: ANTIBIOTICS; SEQUENCE analysis; GENETIC mutation

• Source: Clinical Infectious Diseases; Dec2021, Vol. 73 Issue 11, pe4472-e4474, 3p

Record details

Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.

• Authors : Rincon, Sandra; Panesso, Diana; Miller, William R

Subjects: ENTEROCOCCUS; ANTIBIOTICS; NEUTROPHILS

• Source: Journal of Infectious Diseases; Aug2019, Vol. 220 Issue 3, p494-504, 11p

Record details

Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.

• Authors : Munita, Jose M.; Aitken, Samuel L.; Miller, William R.

Subjects: CARBAPENEMS; CARBAPENEMASE; ANTI-infective agents

• Source: Clinical Infectious Diseases; Jul2017, Vol. 65 Issue 1, p158-161, 4p

Record details

Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics.

• Authors : Matthew J. Ellis; Tao, Yu; Luo, Jingqin

Subjects: CANCER in women; BREAST cancer; ADJUVANT treatment of cancer

• Source: JNCI: Journal of the National Cancer Institute; 10/1/2008, Vol. 100 Issue 19, p1380-1388, 9p, 1 Diagram, 4 Charts, 2 Graphs

Record details

Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter?

• Authors : MILLER, WILLIAM R.; BARTLETT, JOHN; BRODIE, ANGELA M. H.

Subjects: AROMATASE; ENZYME inhibitors; BREAST cancer

• Source: Oncologist; Aug2008, Vol. 13 Issue 8, p829-837, 9p, 2 Diagrams, 2 Charts, 1 Graph

Record details